Local control of thyroid hormone action: role of type 2 deiodinase
Deiodinases: the balance of thyroid hormone
- Molecular Endocrinology Group, Department of Medicine and Medical Research Council Clinical Sciences Centre, Imperial College London, Hammersmith Hospital, Commonwealth Building 7th Floor, Du Cane Road, London W12 0NN, UK
- (Correspondence should be addressed to G R Williams; Email: graham.williams{at}imperial.ac.uk)
-
Figure 1
Negative feedback regulation of the hypothalamic–pituitary–thyroid axis. The role of DIO2 in negative feedback control of the HPT axis occurs predominantly in thyrotrophs of the anterior pituitary gland. PVN, para-ventricular nucleus; TRH, thyrotropin-releasing hormone; DIO2, type 2 deiodinase enzyme; TRβ2, thyroid hormone receptor β2; T4, thyroxine; T3, 3,5,3′-l-triiodothyronine.
-
Figure 2
Regulation of intracellular supplies of T3 to the nucleus of T3 target cells. MCT8 and MCT10, monocarboxylate transporters 8 and 10; OATP1C1, organic acid transporter protein-1C1; DIO2 and DIO3, type 2 and 3 deiodinase enzymes; TR, thyroid hormone receptor, RXR, retinoid X receptor; T4, thyroxine; T3, 3,5,3′-l-triiodothyronine; rT3, 3,3′,5′-triiodothyronine; T2, 3,3′-diiodothyronine.
- © 2011 Society for Endocrinology